Trial intelligence / Profile preview

Hyaluronic Acid for Papilla Augmentation

NCT02536807Completed

Sponsor
Malmö University
Start
Aug 2014
Primary completion
May 2016
Modality
Device-based Delivery
Countries
1
01

Overview

Randomised, double-blind trial of cross-linked hyaluronic acid (2 arms), sponsored by Malmö University. Primary endpoint: Distance between papilla tip and contact point at 6 months. Started Aug 2014; status: completed.

02

Drugs

cross-linked hyaluronic acid

Beyond the preview

Go deeper on NCT02536807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02536807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call